COMPARISON OF OUTCOMES AFTER DONOR LYMPHOCYTE INFUSION WITH OR WITHOUT PRIOR CHEMOTHERAPY FOR MINIMAL RESIDUAL DISEASE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

被引：0
作者：
Mo, X. -D. [1 ]
Zhang, X. -H. [1 ]
Xu, L. -P. [1 ]
Wang, Y. [1 ]
Yan, C. -H. [1 ]
Chen, H. [1 ]
Chen, Y. -H. [1 ]
Han, W. [1 ]
Wang, F. -R. [1 ]
Wang, J. -Z. [1 ]
Liu, K. -Y. [1 ]
Huang, X. -J. [1 ]
机构：
[1] Peking Univ, Peoples Hosp, Inst Hematol, Beijing, Peoples R China
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E1515
引用
收藏
页码：618 / 618
页数：1
相关论文
共 50 条
  • [21] Panobinostat and decitabine prior to donor lymphocyte infusion in allogeneic stem cell transplantation
    Kalin, Burak
    van Norden, Yvette
    van Gelder, Michel
    Breems, Dimitri
    Maertens, Johan
    Jongen-Lavrencic, Mojca
    Broers, Annoek E. C.
    Braakman, Eric
    Grob, Tim
    Zeijlemaker, Wendelien
    Ossenkoppele, Gert J.
    Meijer, Ellen
    Cornelissen, Jan J.
    BLOOD ADVANCES, 2020, 4 (18) : 4430 - 4437
  • [22] ADOPTIVE THERAPY WITH DONOR LYMPHOCYTE INFUSION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION - EXPERIENCE OF THE POLISH PEDIATRIC GROUP FOR HEMATOPOIETIC STEM CELL TRANSPLANTATION (PPGHSCT)
    Gozdzik, J.
    Rewucka-siewiera, K.
    Krasowska-Kwiecien, A.
    Pieczonka, A.
    Debski, R.
    Zaucha-Prazmo, A.
    Drabko, K.
    Kowalczyk, J.
    Wysocki, M.
    Gorczynska, E.
    Kalwak, K.
    Chybicka, A.
    Wachowiak, J.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S159 - S160
  • [23] Donor Lymphocyte Infusion for the Treatment and Prevention of Recurrence After Hematopoietic Stem Cell Transplantation
    Liao, Jianyun
    Long, Lina
    Li, Chunfu
    Zhou, Xiaohui
    Liu, Qifa
    BLOOD, 2012, 120 (21)
  • [24] Treatment of leukemia relapse after allogeneic hematopoietic stem cell transplantation by donor lymphocyte infusion and STI-571
    Baron, F
    Frère, P
    Fillet, G
    Beguin, Y
    HAEMATOLOGICA, 2001, 86 (09) : 993 - 994
  • [25] DONOR-LYMPHOCYTE INFUSION IN PATIENTS WITH PERSISTENT OR RECURRENT MULTIPLE MYELOMA AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Beitinjaneh, A.
    Shah, N.
    Bashir, Q.
    Parmar, S.
    Hosing, C.
    Popat, U.
    Anderlini, P.
    Dinh, Y.
    Qureshi, S.
    Rondon, G.
    Champlin, R. E.
    Giralt, S.
    Qazilbash, M. H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S340 - S340
  • [26] An Experience of Donor Lymphocyte Infusion after Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease
    Rostami, Tahereh
    Kiumarsi, Azadeh
    PEDIATRIC REPORTS, 2020, 12 (03) : 149 - 154
  • [27] Tumor-specific Donor Lymphocyte Infusion after Allogeneic Hematopoietic Cell Transplantation.
    Tawara, Isao
    Katayama, Naoyuki
    Shiku, Hiroshi
    Ikeda, Hiroaki
    CANCER SCIENCE, 2018, 109 : 757 - 757
  • [28] Minimal Residual Disease following Allogeneic Hematopoietic Stem Cell Transplantation
    Kroeger, Nicolaus
    Miyamura, Koichi
    Bishop, Michael R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (01) : S94 - S100
  • [29] Treatment of lymphoma relapses after allogeneic hematopoietic stem cell transplantation with intensive chemotherapy followed by infusion of hematopoietic stem cell from the original donor
    W. Y. Au
    A. K. W. Lie
    L. L. P. Siu
    E. C. Chan
    G. C. Ooi
    A. Y. H. Leung
    R. Liang
    Y. L. Kwong
    Annals of Hematology, 2003, 82 : 548 - 551
  • [30] Treatment of lymphoma relapses after allogeneic hematopoietic stem cell transplantation with intensive chemotherapy followed by infusion of hematopoietic stem cell from the original donor
    Au, WY
    Lie, AKW
    Siu, LLP
    Chan, EC
    Ooi, GC
    Leung, AYH
    Liang, R
    Kwong, YL
    ANNALS OF HEMATOLOGY, 2003, 82 (09) : 548 - 551
12345